Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 4.15B | 2.19B | 1.19B | 401M |
| Cost of revenue | 451M | 227M | 118M | 29M |
| Research and development | 1.36B | 983M | 859M | 663M |
| Selling, general and administrative | 1.37B | 1.06B | 712M | 472M |
| Operating income | 1.05B | −22M | −425M | −720M |
| Pre-tax income | 1.28B | 85M | −304M | −729M |
| Income tax | −13M | −748M | −9M | −20M |
| Net income | 1.29B | 833M | −295M | −710M |
| Earnings per share | 21.08 | 13.92 | −5.16 | −13.05 |
| Earnings per share, diluted | 19.57 | 12.78 | −5.16 | −13.05 |
| Weighted average shares | 61M | 60M | 57M | 54M |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 3.49B | 1.50B | 2.05B | 801M | 1.33B |
| Receivables | — | 1.65B | 904M | 497M | 276M | — |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | 685M | −83M | −420M | −863M |
| Share-based compensation | 248M | 235M | 233M | 157M |
| Capital expenditure | 6M | 2M | 812,000 | 837,000 |
| Investing cash flow |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| Inventory | — | 474M | 407M | 311M | 228M | — |
| Current assets | — | 6.90B | 4.88B | 4.12B | 2.77B | — |
| Total assets | — | 8.68B | 6.20B | 4.54B | 3.13B | — |
| Current liabilities | — | 1.32B | 670M | 423M | 302M | — |
| Total liabilities | — | 1.36B | 704M | 445M | 321M | — |
| Equity | — | 7.32B | 5.50B | 4.10B | 2.81B | 2.53B |
| 984M |
| −718M |
| 308M |
| −461M |
| Financing cash flow | 233M | 280M | 1.34B | 844M |